http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113952342-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed45040c25720954487cd2e14c16052a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
filingDate 2021-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_100803372b8dd84dc12b3780d8dde588
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7bfb5fcddbecae4b02967117e0ed65f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37fadf6028784028008f6820d3f5a68e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e7c383a359d877537a4fd4bdf7ab02a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cf0e458b0f031cc37a5f7abd9397609
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78c5027b82e3e1d38ac1c709de7151a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3db50ffc85b7cf6eaefc41961b2bb850
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b840d867f3eb40551add0a4a8185880c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_262f7d6c4daa7dfa4c371bf24dcb3088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c7e1df2aa38b28298e5574fb6efddfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4f15b0316d960fa7a3d48367378e4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44355760ffaba77dda0cae2ef8107566
publicationDate 2022-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113952342-A
titleOfInvention Application of small molecule compound
abstract The invention provides an application of a small molecular compound, and the compound can be used for preparing a medicament for preventing or treating leukemia or lung cancer; wherein the small molecule compound is a compound 3 beta, 5 alpha, 9 alpha-trihydroxyyergosta-7, 22-dien-6-one of a structural formula (I). The compound of the structural formula (I) provided by the invention has good anti-tumor activity, can obviously inhibit the proliferation activity of tumor cells, influence the tumor cell cycle, promote the apoptosis of the tumor cells and inhibit the healing capacity of cell scratches, and has wide application prospect.
priorityDate 2021-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141000101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432532861

Total number of triples: 32.